✦ LIBER ✦

Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer

✍ Scribed by William E. Evans; Joseph A. Sinkule; William R. Crom; Lois Dow; A. Thomas Look; Gaston Rivera

Publisher: Springer
Year: 1982
Tongue: English
Weight: 328 KB
Volume: 7
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00254537

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide (VP16-213) and teniposide (VM2

Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors

✍ Brian F. Issell; Claude Tihon; M. Elaine Curry 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 247 KB

Determination of etoposide (VP16-213) an

Determination of etoposide (VP16-213) and teniposide (VM-26) in serum by high-performance liquid chromatography with electrochemical detection

✍ James M. Rideout; David C. Ayres; C.K. Lim; T.J. Peters 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 296 KB

Potentiation by novobiocin of the cytoto

Potentiation by novobiocin of the cytotoxic activity of etoposide (VP-16) and teniposide (VM-26)

✍ Germana Rappa; Aurelio Lorico; Alan C. Sartorelli 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 884 KB

The effect of the two epipodophyllotoxin

The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung

✍ Henrik Roed; Lars L. Vindelov; Ib J. Christensen; Mogens Spang-Thomsen; Heine Ho 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 406 KB

Pharmacokinetics and toxicity of the epi

Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma

✍ C. J. Brindley; Pari Antoniw; E. S. Newlands; K. D. Bagshawe 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 527 KB

Pharmacokinetics of teniposide (VM 26) a

Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma

✍ P. Canal; R. Bugat; C. Michel; H. Roche; G. Soula; P. F. Combes 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 315 KB

Nine patients with ovarian carcinoma and malignant ascites treated with IV teniposide chemotherapy (30 mg/m2/30 min) entered this study. Plasma and peritoneal fluid levels were measured by an HPLC method with electrochemical detection. Plasma decay kinetics followed a triexponential function. A high